FDA Inspection 1270219 - Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD. - April 18, 2025
FDA Inspection 1270219 for Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD. on April 18, 2025. Classification: N/A.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1270219 for Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD. on April 18, 2025. Classification: N/A.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
April 18, 2025
Product Type
Human Drugs
ID: 6adc76cc-4f03-4840-a6cc-2a1cef8dba84
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox